Meet the under-35s shaping the future of biotech
MIT Technology Review highlights nine young innovators under 35 who are transforming biotechnology, with five featured for their groundbreaking work in areas like maternal health, brain interfaces, gene therapy, age reversal, and AI-designed viruses.
Intelligence analysis by Gemini 2.5 Flash
This article showcases a selection of young scientists and engineers recognized by MIT Technology Review for their significant contributions to biotech. Their innovations range from practical medical devices for developing countries to advanced gene-editing techniques, cellular reprogramming for age-related diseases, and novel applications of artificial intelligence in biological design.
Imagine brilliant young scientists, some not much older than your older siblings, who are inventing amazing new things to help people and the planet. One made a special wrap to help moms after childbirth, another designed tiny, flexible wires for brains like paper art, and someone else used a smart computer program, like a super-brain, to invent new tiny viruses that could one day make medicines or clean up messes. They're all making the future of health and science much cooler!
Analysis
Every year, MIT Technology Review identifies 35 innovators under the age of 35 whose work is poised to significantly impact their respective fields. This year's cohort includes nine individuals making strides in biotechnology, with a spotlight on five whose projects span critical areas of medical and biological advancement. Their collective efforts underscore a future where complex health challenges and fundamental biological questions are tackled with novel, often interdisciplinary, approaches.
Paschal Kija
Paschal Kija, a 28-year-old innovator from Tanzania, has addressed a critical issue in maternal health: postpartum hemorrhage. This complication is a leading cause of maternal deaths in his home country, accounting for nearly a third of all fatalities. Kija's invention, the Mkanda Salama, which translates to "Safe Wrap," is a low-cost, user-friendly device designed to stop postpartum bleeding.
Clinical studies have demonstrated the device's effectiveness, showing it halted bleeding in 73% of women within 20 minutes. This innovation represents a significant step towards reducing maternal mortality rates in resource-limited settings, offering a practical and affordable solution where advanced medical infrastructure may be scarce. The simplicity and cost-effectiveness of the Mkanda Salama highlight the potential for localized innovation to have a profound global impact on public health.
Kirigami
Xiao Yang, 34, is pushing the boundaries of neurotechnology by developing ultra-small and flexible brain electrodes. Traditional brain electrodes, while vital for understanding brain activity and treating neurological disorders, carry the risk of damaging surrounding brain tissue due to their rigid and invasive nature. Yang's work aims to mitigate this risk by creating electrodes that are less impactful and more biocompatible.
Her innovative approach draws inspiration from kirigami, the traditional Japanese art of paper cutting to create three-dimensional shapes. By applying kirigami principles, Yang has designed sheets of electrodes with a honeycombed, spiral-basket structure that mimics the flexibility and intricate forms of actual neurons. These flexible electrodes are already being utilized to study brain cells in laboratory settings, promising a future where brain interfaces are both more effective and less harmful.
Samuel King
Samuel King, at 27, is at the forefront of integrating artificial intelligence with biological design, specifically in the creation of novel viruses. He utilized a generative AI model to produce new genetic blueprints for bacteriophages, which are viruses that specifically infect and kill bacteria. This application of AI moves beyond traditional drug discovery methods, allowing for the rapid generation of entirely new biological entities.
After obtaining the AI-designed blueprints, King synthesized them into DNA strands. Experiments confirmed that these AI-engineered viruses were functional: they could replicate themselves, lyse bacterial cells, and infect other bacteria. King envisions a future where AI-designed biological forms, though not alive in the conventional sense, could be harnessed for diverse applications, including the development of new therapeutic drugs or even for environmental remediation, such as soaking up pollution.
Key points
- MIT Technology Review's '35 Innovators Under 35' list includes nine individuals transforming biotech.
- Paschal Kija developed the Mkanda Salama, a $70 device that stops postpartum hemorrhage, a leading cause of maternal deaths in Tanzania.
- Xiao Yang is creating ultra-small, flexible brain electrodes inspired by kirigami to reduce damage to brain tissue.
- Sarah Grandinette was part of a team that developed a personalized gene-editing therapy for a baby with a rare genetic disorder.
- Yuancheng (Ryan) Lu's work on cellular reprogramming has reversed vision loss in blind mice, with human trials now underway for eye disease.
- Samuel King used generative AI to design new bacteriophages, demonstrating AI's potential in creating novel biological forms for drugs or pollution control.
These innovations promise significant advancements in global health, from reducing maternal mortality in developing nations to offering personalized gene therapies for rare diseases. The integration of AI in biological design could accelerate the discovery of new treatments and environmental solutions, leading to a healthier and more sustainable future.
While promising, the development of brain electrodes still carries inherent risks of tissue damage, and the long-term effects of novel gene therapies or AI-designed biological entities require extensive testing and ethical consideration before widespread application.
